Total Utang marang Modal Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals, Inc. - logo grafis emiten ATNM

Actinium Pharmaceuticals (ATNM) bases its operations on New York-based radiopharmaceutical centers, while isotope synthesis is entrusted to specialized nuclear laboratories with enhanced security. This chart of the share price demonstrates the 0.04 metric. The business relies on external contractors for clinical trials, manufacturing, and global logistics to maintain a maximum focus on discovering blood cancer therapies.

actiniumpharma.com (ATNM): Rasio Utang marang Ekuitas saka 04.07.2022 nganti 01.11.2026

Rincian metrik lan analitis perusahaan Actinium Corp (ATNM)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Actinium Pharmaceuticals, Inc.|ATNM - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Actinium Pharmaceuticals|ATNM - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Actinium Pharmaceuticals|ATNM - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku actiniumpharma.com|ATNM - Gunggung Aset Perusahaan
- rincian utang lan likuiditas:
Total Utang marang Modal Actinium Pharmaceuticals|ATNM - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Actinium Pharmaceuticals|ATNM - Kewajiban utang agregat|Utang marang nilai buku Actinium Pharmaceuticals|ATNM - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Actinium Pharmaceuticals|Likuiditas cepet actiniumpharma.com
- data bathi resik lan rasio valuasi:
ATNM - Bathi resik perusahaan
Pambiji fundamental perusahaan:Actinium Pharmaceuticals, Inc.
Produk dadi Actinium Pharmaceuticals

Developing a targeted radiotherapy ecosystem for hematology requires significant investment, making financial leverage control critically important. By analyzing the debt-to-equity ratio, an investor assesses the proportion of borrowed capital within the balance sheet structure, where a decrease in this metric confirms the high autonomy and stability of Actinium Pharmaceuticals (ATNM) market value in the face of debt risks.

Analisis pesaing Actinium Pharmaceuticals

TGTX (TG Therapeutics) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Arcellx Inc (ACLX)|Total Utang marang Modal IRON|Total Utang marang Modal Syndax Corp (SNDX)|Utang marang Ekuitas Kura Oncology, Inc. KURA|ADCT: Rasio Utang marang Ekuitas|Foghorn - Total Utang marang Modal|Vor Biopharma, Inc. (VOR) - Rasio Total Utang marang Ekuitas|NKTX: Total Utang marang Modal|Utang marang Modal Coeptis Therapeutics, Inc. (COEP)|Utang marang Ekuitas Estrella Immunopharma|CASI: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas MRKR (Marker Therapeutics)|INAB (IN8bio Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ERNA (Eterna Therapeutics Inc.)|GT Biopharma Corporation - Utang marang Ekuitas|APTO - Utang marang Ekuitas|BPTH: Utang marang Ekuitas|MEI Pharma (MEIP) - Utang marang Ekuitas|Utang marang Modal Vincerx Pharma (VINC)